TMCnet News

ZS Genetics, Inc. to Vie for Ten Million Dollar Archon X PRIZE for Genomics
[April 23, 2008]

ZS Genetics, Inc. to Vie for Ten Million Dollar Archon X PRIZE for Genomics


(Market Wire Via Acquire Media NewsEdge) SANTA MONICA, CA, April 23 / MARKET WIRE/ --

ZS Genetics, Inc. is the seventh team to
be accepted into the ten million dollar Archon X PRIZE for Genomics
competition. Led by William Glover, an engineer and inventor, ZS Genetics
was founded in 2003. The company, which is based in North Reading,
Massachusetts, is finalizing development of a technology platform for
directly creating detailed images of individual DNA or RNA molecules using
modified transmission electron microscopes and atomic labeling. The team
consists of professors, biologists, engineers and businessmen, and includes
strategic relationships with universities and component makers.

"We're extremely excited to have ZS Genetics join the race as our seventh
official team," said Marc Hodosh, Senior Director for the Archon X PRIZE
for Genomics. "Expanding the field of competitors not only increases the
chances of a winner, but increases the support and public awareness towards
the quest of rapid and cost-effective whole human genome sequencing. ZS
Genetics is a serious competitor with a very interesting approach, and we
applaud their focus and effort to reach this challenging, yet attainable
goal."

The Archon X PRIZE for Genomics is the second prize launched by the X PRIZE
Foundation following the success of the Ansari X PRIZE for sub-orbital
spaceflight. To win the $10 million genomics prize purse, teams must
successfully sequence 100 human genomes within 10 days for less than
$10,000 per genome. This accomplishment is a necessary step to create a new
era of personalized, predictive and preventive medicine, eventually
transforming medical care from reactive to proactive.

"This competition isn't about consensus or tradition or administrative
approval," said ZS Genetics Founder, William Glover. "The Archon X PRIZE
competition provides exactly the focus and immediacy needed to drive
pioneers and innovators forward. We believe our approach will win, but
whichever team receives the prize, all humanity will share in the advances
that have been encouraged by the X PRIZE."

ABOUT THE X PRIZE FOUNDATION

The X PRIZE Foundation is an educational nonprofit prize institute whose
mission is to create radical breakthroughs for the benefit of humanity. In
2004, the Foundation captured world headlines when Burt Rutan, backed by
Microsoft co-founder Paul Allen, built and flew the world's first private
vehicle to space to win the $10 million Ansari X PRIZE. The Foundation has
since launched the $10 million Archon X PRIZE for Genomics, the $30 million
Google Lunar X PRIZE, and the $10 million Progressive Automotive X PRIZE.
The Foundation is creating prizes in five areas: Exploration (Space and



Underwater), Life Sciences, Energy & Environment, Education and Global
Development. The Foundation is widely recognized as the leading model for
fostering innovation through competition. For more information, please
visit www.xprize.org. For more information on the Archon X PRIZE for
Genomics, please visit http://genomics.xprize.org.

ABOUT ZS GENETICS


ZS Genetics (www.zsgenetics.com) is a privately held company based in the
northeastern USA that is finalizing development of a technology platform
for directly creating detailed images of individual DNA or RNA molecules,
using modified transmission electron microscopes and atomic labeling. ZS
Genetics' technology offers the prospect of revolutionary advancements in
genetic analysis, with applications in the sequencing, expression and
diagnostics markets. The technology shows the promise of sequencing whole
human genomes in days instead of months, for thousands of dollars instead
of millions; and with long base pair read-lengths, which allow the
detection of long repeating patterns in a genetic code. The technology
could change the multi-billion-dollar marketplace dynamics for genetic
information applications, including enabling widespread adoption of
genetics-based medicine, and driving important innovation in disease
research, drug discovery, forensics, environmental impact studies,
agriculture, anthropology and history.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contacts:
Sarah Evans
[email protected]
Thomas Abert
[email protected]
Denise Drace-Brownell
[email protected]

Copyright ? 2008 Market Wire, Incorporated

[ Back To TMCnet.com's Homepage ]